ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CELL PhenomeX Inc

0.9981
0.00 (0.00%)
Apr 11 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
PhenomeX Inc CELL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.9981 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.9981 0.9981
more quote information »

Recent News

Date Time Source Heading
2/08/202417:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/12/202309:00EDGAR2Form 15-12G - Securities registration termination [Section..
10/03/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202314:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202317:16EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
10/02/202317:06EDGAR2Form S-8 POS - Securities to be offered to employees in..
10/02/202308:47EDGAR2Form 8-K - Current report
9/29/202308:30EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
9/27/202308:51PRNUSPhenomeX Announces Opto® Memory B Discovery Human Workflow..
9/21/202308:35PRNUSPhenomeX Announces the Release of SpotLight™ Human Lambda..
9/20/202308:48PRNUSPhenomeX to Participate in Upcoming Cell Biology Conferences
9/20/202306:05EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
9/15/202309:08PRNUSPhenomeX Unveils Meteor™ Chips For Quantitative Bulk..
9/05/202316:02PRNUSPhenomeX Inc. Announces Commencement of Cash Tender Offer by..
8/31/202316:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
8/28/202317:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
8/18/202317:21EDGAR2Form SC14D9C - Written communication relating to third party..
8/17/202317:28EDGAR2Form SC14D9C - Written communication relating to third party..
8/17/202317:27EDGAR2Form 8-K - Current report
8/17/202309:10EDGAR2Form SC14D9C - Written communication relating to third party..
8/17/202309:09EDGAR2Form 8-K - Current report
8/17/202309:00BWBruker Corporation and PhenomeX Inc. Announce Definitive..
8/14/202316:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202316:09EDGAR2Form 8-K - Current report
8/14/202316:05PRNUSPhenomeX Reports Second Quarter 2023 Financial Results and..
8/09/202316:25PRNUSPhenomeX to Report Second Quarter 2023 Financial Results on..
8/07/202308:11PRNUSPhenomeX Announces Lifting of the Stay in AbCellera Patent..
7/28/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/26/202318:15EDGAR2Form 144 - Report of proposed sale of securities
7/07/202316:15EDGAR2Form 8-K - Current report
6/13/202309:32PRNUSPhenomeX's Beacon® Technology Enables Early Identification..
6/05/202308:46PRNUSPhenomeX Launches Beacon Quest™ Optofluidic System with..
5/15/202309:01PRNUSPhenomeX Launches Beacon Select™ Optofluidic System with..
5/11/202316:02PRNUSPhenomeX Reports First Quarter 2023 Financial Results
5/11/202309:35PRNUSPhenomeX To Participate in 19th Annual PEGS Boston..
4/27/202317:27PRNUSPhenomeX to Report First Quarter 2023 Financial Results on..
4/17/202307:30PRNUSPhenomeX Launches the Opto® T Cell Profiling Workflow

Your Recent History

Delayed Upgrade Clock